- Disease area(s): HIV/AIDS, tuberculosis, malaria
- Company(ies): Abbott, Bristol-Myers Squibb, Pfizer
- Partner(s): (Kenya MoH, USAID, PEPFAR & other partners)
- Since 2009
- Program type(s): Capacity Building - Support
- Developing country(ies): Kenya
- Contact(s):
- IFPMA ID: 1300
Health at Home/Kenya is an initiative coordinated by Global Business Coalition on HIV/AIDS, Tuberculosis & Malaria (GBC) that is providing home-based HIV/AIDS testing, TB screening and malaria bed nets, and de-worming for children into the homes of millions of Kenyans in a remote region with difficult access to health care. This innovative door-to-door model includes community preparation by local volunteers.
To date, 97% of households in communities reached by the Health at Home/Kenya Impact Initiative have welcomed HIV counselors inside their homes. More than 3,000 people have been found to be HIV positive and directly connected to treatment programs.
On-the-ground implementation of Health at Home/Kenya is being managed by the Academic Model Providing Access to Healthcare (AMPATH), based in Eldoret, Kenya, working closely with the Kenyan government and PEPFAR.
This two-year initiative is supported by PEPFAR and GBC member companies. The initiative is being brought to scale by industry competitors working side-by-side in common cause - serving as a model to be replicated in other AIDS endemic regions of the world.
Participants in the initiative include the Abbott Fund, Accenture, Bristol-Myers Squibb Foundation, Standard Bank Group, Coca-Cola, Deutsche Post DHL, Pfizer, Premier Medical Corporation, SAB Miller, Standard Chartered Bank.


